Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules.
Using site-directed mutagenesis informed by high-resolution CD4 structural data, we have investigated the role of residues of the C'C'' ridge region of human CD4 on class II major histocompatibility complex (MHC) binding. This C'C'' ridge is homologous to the CDR2 loop of an immunoglobulin variable domain and is known to contain the binding site for human immunodeficiency virus (HIV) coat glycoprotein gp120. Here we report that this region is also involved in interaction with class II MHC. Exposed positively charged residues Lys-35, Lys-46, and Arg-59 and the exposed hydrophobic residue Phe-43 contribute significantly to class II MHC binding. Moreover, mutations in the buried residues Trp-62 and Ser-49, which support the top and bottom of the C'C'' ridge, respectively, disrupt class II MHC interaction. The HIV binding region appears to involve a restricted area of the larger class II MHC binding site on CD4. Strategies of drug design aimed at interrupting CD4-HIV interaction will need to consider the extensive overlap between class II MHC and HIV gp120 binding surfaces in this region of CD4.
Moebius
U
U
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA.
Clayton
L K
LK
Abraham
S
S
Diener
A
A
Yunis
J J
JJ
Harrison
S C
SC
Reinherz
E L
EL
D000818:Animals; D001665:Binding Sites; D015704:CD4 Antigens / Q000378:metabolism*; D002448:Cell Adhesion; D002522:Chlorocebus aethiops; D015699:HIV Envelope Protein gp120 / Q000378:metabolism*; D006681:HLA-D Antigens / Q000378:metabolism*; D066298:In Vitro Techniques; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D017354:Point Mutation; D011110:Polymorphism, Genetic; D011485:Protein Binding; D014407:Tumor Cells, Cultured
D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D006681:HLA-D Antigens